Literature DB >> 8737003

Subtypes of alcoholism and their role in therapy.

O M Lesch1, H Walter.   

Abstract

In recent years, the term 'chronic alcoholism' has had a meaning that is more descriptive than diagnostic. Several subtypes of alcoholism have been established and are now a necessary tool for studying therapy outcome. Alcohol-dependent patients can be subtyped based on clearly assigned dimensions (e.g. biological, sociological and psychological disturbances). Craving and the underlying disturbance must be treated. The number of pharmacological agents that may reduce alcohol intake has increased recently. We conducted a prospective long-term study based on four subtypes of alcohol-dependent patients to assess the efficacy of acamprosate. Our findings demonstrate that these patient subtypes are relevant to outcome in trials of pharmacological agents. We strongly recommend subtyping alcohol-dependent subjects in future trials, because the usefulness of effective drugs could be overlooked when they are tested in a heterogeneous population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737003

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  21 in total

1.  Personality profile in type I alcoholism: long duration of alcohol intake and low serotonergic activity are predictive factors of anxiety proneness.

Authors:  K Berglund; C Fahlke; U Berggren; M Eriksson; J Balldin
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

Review 2.  Typologies of alcohol dependence. From Jellinek to genetics and beyond.

Authors:  Lorenzo Leggio; George A Kenna; Miriam Fenton; Erica Bonenfant; Robert M Swift
Journal:  Neuropsychol Rev       Date:  2009-01-31       Impact factor: 7.444

3.  Reward, Relief and Habit Drinking: Initial Validation of a Brief Assessment Tool.

Authors:  Erica N Grodin; Spencer Bujarski; Alexandra Venegas; Wave-Ananda Baskerville; Steven J Nieto; J David Jentsch; Lara A Ray
Journal:  Alcohol Alcohol       Date:  2019-12-01       Impact factor: 2.826

Review 4.  Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.

Authors:  Lars Oreland; Gianvito Lagravinese; Simone Toffoletto; Kent W Nilsson; Jaanus Harro; C Robert Cloninger; Erika Comasco
Journal:  J Neural Transm (Vienna)       Date:  2017-01-04       Impact factor: 3.575

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 6.  Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.

Authors:  C Gianoulakis
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

7.  Subtypes of Alcohol Dependence and 36-Year Mortality.

Authors:  Michie N Hesselbrock; Victor M Hesselbrock; Grace Chan; Frances Del Boca; Karen Chartier
Journal:  Alcohol Clin Exp Res       Date:  2020-07-23       Impact factor: 3.455

8.  Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

Authors:  Roel Verheul; Philippe Lehert; Peter J Geerlings; Maarten W J Koeter; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

Review 9.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

Review 10.  Addictions Neuroclinical Assessment: A reverse translational approach.

Authors:  Laura E Kwako; Reza Momenan; Erica N Grodin; Raye Z Litten; George F Koob; David Goldman
Journal:  Neuropharmacology       Date:  2017-03-07       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.